"Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Vaccines or candidate vaccines used to prevent PAPILLOMAVIRUS INFECTIONS. Human vaccines are intended to reduce the incidence of UTERINE CERVICAL NEOPLASMS, so they are sometimes considered a type of CANCER VACCINES. They are often composed of CAPSID PROTEINS, especially L1 protein, from various types of ALPHAPAPILLOMAVIRUS.
| Descriptor ID |
D053918
|
| MeSH Number(s) |
D20.215.894.899.498
|
| Concept/Terms |
Human Papillomavirus Vaccines- Human Papillomavirus Vaccines
- Papillomavirus Vaccines, Human
- Vaccines, Human Papillomavirus
- Human Papilloma Virus Vaccines
- HPV Vaccines
|
Below are MeSH descriptors whose meaning is more general than "Papillomavirus Vaccines".
Below are MeSH descriptors whose meaning is more specific than "Papillomavirus Vaccines".
This graph shows the total number of publications written about "Papillomavirus Vaccines" by people in this website by year, and whether "Papillomavirus Vaccines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 2 | 3 |
| 2009 | 6 | 1 | 7 |
| 2010 | 3 | 0 | 3 |
| 2011 | 4 | 0 | 4 |
| 2012 | 3 | 1 | 4 |
| 2013 | 4 | 2 | 6 |
| 2014 | 5 | 0 | 5 |
| 2015 | 6 | 1 | 7 |
| 2016 | 14 | 1 | 15 |
| 2017 | 11 | 4 | 15 |
| 2018 | 8 | 5 | 13 |
| 2019 | 9 | 5 | 14 |
| 2020 | 10 | 2 | 12 |
| 2021 | 13 | 1 | 14 |
| 2022 | 13 | 0 | 13 |
| 2023 | 9 | 0 | 9 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Papillomavirus Vaccines" by people in Profiles.
-
HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of healthcare providers' knowledge, training, and recommendation practices. Front Public Health. 2024; 12:1343064.
-
Barriers and determinants of consistent offering of HPV vaccination by healthcare facilities. Hum Vaccin Immunother. 2023 08; 19(2):2264596.
-
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention. Cancer Prev Res (Phila). 2023 09 01; 16(9):483-495.
-
Barriers to human papillomavirus vaccine uptake: role of state religiosity and healthcare professionals' participation in a state vaccine program. JNCI Cancer Spectr. 2023 08 31; 7(5).
-
The influence of political ideology on awareness of HPV and HPV vaccine among adults in the United States. Hum Vaccin Immunother. 2023 08 01; 19(2):2232706.
-
Individual, systemic and state factors associated with provider recommendation of HPV vaccination: Findings from NIS-Teen, 2020. Hum Vaccin Immunother. 2023 08 01; 19(2):2239678.
-
Reasons patients cite to their health-care professional for not initiating or completing human papillomavirus vaccination. JNCI Cancer Spectr. 2023 07 03; 7(4).
-
Parents' stigmatizing beliefs about the HPV vaccine and their association with information seeking behavior and vaccination communication behaviors. Hum Vaccin Immunother. 2023 12 31; 19(1):2214054.
-
Application of the theoretical domains framework to identify factors influencing catch-up HPV vaccinations among male college students in the United States: A review of evidence and recommendations. Vaccine. 2023 05 26; 41(23):3564-3576.
-
Human Papillomavirus Vaccination Prevalence and Disproportionate Cancer Burden Among US Veterans. JAMA Oncol. 2023 05 01; 9(5):712-714.